Suppr超能文献

急性缺血性卒中后出血性转化风险因素分析

Analysis of Risk Factors Increased Hemorrhagic Transformation after Acute Ischemic Stroke.

作者信息

Ge Wan-Qian, Chen Jie, Pan Hong, Chen Fei, Zhou Cheng-Ye

机构信息

Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Department of Neurology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

出版信息

J Stroke Cerebrovasc Dis. 2018 Dec;27(12):3587-3590. doi: 10.1016/j.jstrokecerebrovasdis.2018.08.028. Epub 2018 Sep 12.

Abstract

BACKGROUND

The purpose of this study was to analyze the risk factors of hemorrhagic transformation (HT) after intravenous thrombolysis using a recombinant tissue plasminogen activator (r-tPA) in acute ischemic stroke (AIS).

METHODS

We included 199 consecutive patients in the First Affiliated Hospital of Wenzhou Medical University from January 2016 to October 2017 with a diagnosis of AIS. The patients were divided into 2 groups: HT and non-HT. The related risk factors were recruited before and after receiving r-tPA thrombolysis.

RESULTS

Using univariate analysis, we found that there was a significant difference between the HT and non-HT group (P < .05) in the level of age, atrial fibrillation, baseline National Institute of Health Stroke Scale (NIHSS) score and NIHSS score after 2 hours of thrombolytic therapy, hyperlipidemia. Multivariate logistic regression analysis indicated that NIHSS score after 2 hours of thrombolytic therapy (odds ratio [OR] = 1.091, 95% confidence interval [CI] = 1.015-1.173 P = .018) and atrial fibrillation (OR = 2.188, 95%CI  = 1.024-4.672 P = .043) are the risk factors of HT.

CONCLUSIONS

NIHSS score after 2 hours of thrombolytic therapy and atrial fibrillation were risk factors for HT after thrombolysis. Age (OR = 1.022, 95%CI = .988-1.056 P = .205), Hyperlipidemia (OR = .591, 95%CI = .29-1.206 P = .148), and Baseline NIHSS score (OR = .998, 95%CI = .914-1.089 P = .043) were not significant independent predictors but showed an association with HT. These 5 factors should be carefully taken into account.

摘要

背景

本研究旨在分析急性缺血性卒中(AIS)患者静脉注射重组组织型纤溶酶原激活剂(r-tPA)溶栓后发生出血性转化(HT)的危险因素。

方法

纳入2016年1月至2017年10月在温州医科大学附属第一医院连续收治的199例确诊为AIS的患者。将患者分为两组:HT组和非HT组。在接受r-tPA溶栓治疗前后收集相关危险因素。

结果

单因素分析发现,HT组和非HT组在年龄、心房颤动、基线美国国立卫生研究院卒中量表(NIHSS)评分、溶栓治疗2小时后的NIHSS评分、高脂血症水平方面存在显著差异(P <.05)。多因素logistic回归分析表明,溶栓治疗2小时后的NIHSS评分(比值比[OR] = 1.091,95%置信区间[CI] = 1.015 - 1.173,P =.018)和心房颤动(OR = 2.188,95%CI = 1.024 - 4.672,P =.043)是HT的危险因素。

结论

溶栓治疗2小时后的NIHSS评分和心房颤动是溶栓后HT的危险因素。年龄(OR = 1.022,95%CI =.988 - 1.056,P =.205)、高脂血症(OR =.591,95%CI =.29 - 1.206,P =.148)和基线NIHSS评分(OR =.998,95%CI =.914 - 1.089,P =.043)不是显著的独立预测因素,但与HT有关联。这5个因素应予以仔细考虑。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验